On Wednesday, Pfizer Inc. (NYSE:PFE) reported first-quarter adjusted EPS of $0.82, down 33% year over year, beating the consensus of $0.54. The company witnesses a significant decrease in Comirnaty and Paxlovid revenues globally and an unfavorable impact of foreign exchange of $107 million, or 1%. The U.S. drugmaker reported sales of $14.9 billion, down 20%, beating the consensus of $14.2 billion. Excluding contributions from Comirnaty and Paxlovid, revenues totaled $12.5 billion, an increase of
Curtiss-Wright Corporation reports financial results for the first quarter ended March 31, 2024.
First Quarter 2024 Highlights:
Reported sales of $713 million, up 13%, operating income of $100.
Earnings in full flow – Focus turns US GDP and Core PCE data fxstreet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fxstreet.com Daily Mail and Mail on Sunday newspapers.